跳至主要内容
临床试验/NCT06960785
NCT06960785尚未招募不适用

Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser

Carl Zeiss Meditec AG3 个研究点 分布在 2 个国家目标入组 75 人开始时间: 2025年5月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
75
试验地点
3
主要终点
Proportion of patients achieving binocular uncorrected near visual acuity (UNVA) of 0.1 logMAR or better

研究概览

简要总结

The goal of this clinical trial is to collect information on vision outcomes in people aged 45 to 65 who have difficulty seeing clearly at near distances due to aging (a condition called presbyopia). All participants will receive the same treatment: laser eye surgery with the PRESBYOND method using the MEL 90 excimer laser.

The main questions this study aims to answer are:

  • How well do patients see at distance, intermediate, and near after treatment?
  • How satisfied are patients with their vision after surgery?

Participants will:

  • Attend seven visits over six months (before surgery and after surgery at 1 day, 1 week, 1 month, 3 months, and 6 months)
  • Undergo laser eye surgery with PRESBYOND
  • Complete vision tests and questionnaires about their experience

There is no comparison group in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects between 45 and 65 years old
  • Scheduled to undergo bilateral LASIK treatment with PRESBYOND
  • Preoperative corrected distance visual acuity of 20/20 Snellen or better in each eye
  • Normal corneal topography in each eye
  • Discontinue use of contact lenses at least 1 month for hard contacts and 1 week for soft lenses prior to the preoperative examination
  • Residual stromal thickness ≥250 microns in each eye
  • Availability, willingness, to comply with examination follow up visits
  • Signed informed consent and data protection documents
  • Patients successfully passed the tolerance test

排除标准

  • Mixed astigmatism in any eye
  • Irregular corneal astigmatism in any eye
  • Clinically significant ocular surface disease in any eye
  • History of ocular surgery, ocular pathology, or other significant ocular findings that, in the Investigator's opinion, may increase the patient's risk for corneal refractive surgery or affect potential visual outcomes in each eye
  • Prior corneal refractive surgery (SMILE, LASIK, LASEK, RK, PRK, etc,) in each eye
  • Amblyopia, strabismus, nystagmus, forme fruste keratoconus in any eye
  • Clinically significant pupil abnormalities in any eye
  • Use of systemic or ocular medications that may affect visual outcomes
  • Systemic pathology that may affect the results of the study
  • Pregnancy or being treated for conditions associated with hormonal fluctuation
  • Participation in another clinical trial in the last 30 days

结局指标

主要结局

Proportion of patients achieving binocular uncorrected near visual acuity (UNVA) of 0.1 logMAR or better

时间窗: 6 months after surgery

The primary endpoint of the study is the proportion of patients achieving a binocular uncorrected near visual acuity (UNVA) of 0.1 logMAR or better at 6 months postoperatively. Near visual acuity is assessed using standardized near vision charts under controlled lighting conditions, following standard clinical protocols. Measurements are taken binocularly to reflect functional vision in daily life.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验